GlycoMimetics Inc. (NASDAQ:GLYC), a pharmaceutical company with a market capitalization of $17.28 million, has announced the impending departure of two top executives, as detailed in a recent 8-K ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback